Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2018, Article ID 2171062, 3 pages
https://doi.org/10.1155/2018/2171062
Case Report

Radiation Recall Dermatitis in Patients Treated with Sorafenib

1Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
2Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

Correspondence should be addressed to Keyur Mehta; gro.eroifetnom@athemk

Received 1 December 2017; Accepted 10 January 2018; Published 24 January 2018

Academic Editor: Peter F. Lenehan

Copyright © 2018 Keyur Mehta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Llovet, S. Ricci, V. Mazzaferro et al., “Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC),” Journal of Clinical Oncology, vol. 25, no. 18, 2007. View at Publisher · View at Google Scholar
  2. C. Chung, L. A. Dawson, A. M. Joshua, and A. M. Brade, “Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib,” Anti-Cancer Drugs, vol. 21, no. 2, pp. 206–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Oh, H. C. Park, H. Y. Lim, and B. C. Yoo, “Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction,” Radiation Oncology Journal, vol. 31, no. 3, pp. 171–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. A. Burris and J. Hurtig, “Radiation recall with anticancer agents,” Oncologist, vol. 15, no. 11, pp. 1227–1237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. H. Hsieh, S.-C. Lin, P.-W. Shueng, and D.-Y. Kuo, “Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy,” OncoTargets and Therapy, vol. 7, pp. 1111–1114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Stieb, O. Riesterer, C. Brüssow, B. Pestalozzi, M. Guckenberger, and S. Weiler, “Radiation recall dermatitis induced by sorafenib: a case study and review of the literature,” Strahlentherapie und Onkologie, vol. 192, no. 5, pp. 342–348, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Azria, N. Magné, A. Zouhair et al., “Radiation recall: a well recognized but neglected phenomenon,” Cancer Treatment Reviews, vol. 31, no. 7, pp. 555–570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Camidge and A. Price, “Characterizing the phenomenon of radiation recall dermatitis,” Radiotherapy and Oncology, vol. 59, no. 3, pp. 237–245, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Ristic, “Radiation recall dermatitis,” International Journal of Dermatology, vol. 43, no. 9, pp. 627–631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. J. Smith, M. Germain, and H. Skelton, “Histopathologic features seen with radiation recall or enhancement eruptions,” Journal of Cutaneous Medicine and Surgery, vol. 6, no. 6, pp. 535–540, 2002. View at Publisher · View at Google Scholar · View at Scopus